MICHELLE CRIGLER: Open Payments
NPI 1063590446 · LANSDOWNE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 28 payments from 9 companies in 2025. Trend: 2023 $945 · 2024 $1,010 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $194 |
| PFIZER INC. | 4 | $123 |
| Janssen Biotech, Inc. | 4 | $84 |
| Novo Nordisk Inc | 3 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Ardelyx, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: VELSIPITY, TREMFYA, RINVOQ, Wegovy, XIFAXAN, LINZESS, REZDIFFRA, IQIRVO.
Industry payments across VA — which companies pay providers there.
